Literature DB >> 31554694

The Deubiquitinating Enzyme Ubiquitin-Specific Peptidase 11 Potentiates TGF-β Signaling in CD4+ T Cells to Facilitate Foxp3+ Regulatory T and TH17 Cell Differentiation.

Roman Istomine1,2,3, Fernando Alvarez1,2,3, Yasser Almadani4,5, Anie Philip4,5, Ciriaco A Piccirillo6,2,3.   

Abstract

Foxp3+ regulatory T (TREG) cells are central mediators in the control of peripheral immune responses. Genome-wide transcriptional profiles show canonical signatures for Foxp3+ TREG cells, distinguishing them from Foxp3- effector T (TEFF) cells. We previously uncovered distinct mRNA translational signatures differentiating CD4+ TEFF and TREG cells through parallel measurements of cytosolic (global) and polysome-associated (translationally enhanced) mRNA levels in both subsets. We show that the mRNA encoding for the ubiquitin-specific peptidase 11 (USP11), a known modulator of TGF-β signaling, was preferentially translated in TCR-activated TREG cells compared with conventional, murine CD4+ T cells. TGF-β is a key cytokine driving the induction and maintenance of Foxp3 expression in T cells. We hypothesized that differential translation of USP11 mRNA endows TREG cells with an advantage to respond to TGF-β signals. In an in vivo mouse model promoting TREG cells plasticity, we found that USP11 protein was expressed at elevated levels in stable TREG cells, whereas ectopic USP11 expression enhanced the suppressive capacity and lineage commitment of these cells in vitro and in vivo. USP11 overexpression in TEFF cells enhanced the activation of the TGF-β pathway and promoted TREG or TH17, but not Th1, cell differentiation in vitro and in vivo, an effect abrogated by USP11 gene silencing or the inhibition of enzymatic activity. Thus, USP11 potentiates TGF-β signaling in both TREG and TEFF cells, in turn driving increased suppressive function and lineage commitment in thymic-derived TREG cells and potentiating the TGF-β-dependent differentiation of TEFF cells to peripherally induced TREG and TH17 cells.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31554694     DOI: 10.4049/jimmunol.1801689

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  The Ubiquitin Proteasome System and Skin Fibrosis.

Authors:  Wanlu Shen; Zhigang Zhang; Jiaqing Ma; Di Lu; Lechun Lyu
Journal:  Mol Diagn Ther       Date:  2021-01-12       Impact factor: 4.074

Review 2.  Molecular mechanism for impaired suppressive function of Tregs in autoimmune diseases: A summary of cell-intrinsic and cell-extrinsic factors.

Authors:  Luting Yang; Gang Wang; Haibin Xia
Journal:  J Cell Mol Med       Date:  2020-09-02       Impact factor: 5.310

Review 3.  Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation.

Authors:  Rirong Chen; Xiaobai Pang; Li Li; Zhirong Zeng; Minhu Chen; Shenghong Zhang
Journal:  Cell Death Dis       Date:  2022-02-10       Impact factor: 9.685

4.  A functional map of HIV-host interactions in primary human T cells.

Authors:  Joseph Hiatt; Judd F Hultquist; Michael J McGregor; Mehdi Bouhaddou; Ryan T Leenay; Lacy M Simons; Janet M Young; Paige Haas; Theodore L Roth; Victoria Tobin; Jason A Wojcechowskyj; Jonathan M Woo; Ujjwal Rathore; Devin A Cavero; Eric Shifrut; Thong T Nguyen; Kelsey M Haas; Harmit S Malik; Jennifer A Doudna; Andrew P May; Alexander Marson; Nevan J Krogan
Journal:  Nat Commun       Date:  2022-04-01       Impact factor: 17.694

Review 5.  Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management.

Authors:  Yihao Liao; Diansheng Zhou; Pu Wang; Mengyue Yang; Ning Jiang
Journal:  Cell Death Discov       Date:  2022-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.